Taylor Hoffman Wealth Management Gilead Sciences, Inc. Transaction History

Taylor Hoffman Wealth Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 29, 2020	SELL	$62.1 - $78.08 $62,100 - $78,080	-1,000 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $72,340 - $84,000	1,000 New	1,000 $77,000
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $81,419 - $104,286	-1,300 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $318,137 - $415,145	-5,255 Reduced 80.17%	1,300 $82,000
Q2 2018 Jul 31, 2018	SELL	$64.88 - $75.68 $2,335 - $2,724	-36 Reduced 0.55%	6,555 $464,000
Q1 2018 May 10, 2018	BUY	$72.84 - $88.8 $6,337 - $7,725	87 Added 1.34%	6,591 $497,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $142,300 - $167,040	2,000 Added 44.4%	6,504 $466,000
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $320,459 - $376,174	4,504	4,504 $323,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Taylor Hoffman Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Taylor Hoffman Wealth Management with notifications on news.